Comments
Loading...

RXO Analyst Ratings

RXONYSE
Logo brought to you by Benzinga Data
$15.25
At close: May 22 EDT
$15.25
0.000.00%
Pre-Market: 4:00 PM EDT
Consensus Rating1
Equal-Weight
Highest Price Target1
$31.00
Lowest Price Target1
$13.00
Consensus Price Target1
$20.85

RXO Analyst Ratings and Price Targets | NYSE:RXO | Benzinga

RXO Inc has a consensus price target of $20.85 based on the ratings of 23 analysts. The high is $31 issued by Wells Fargo on November 11, 2024. The low is $13 issued by Susquehanna on March 26, 2025. The 3 most-recent analyst ratings were released by Citigroup, B of A Securities, and UBS on May 21, 2025, May 16, 2025, and May 8, 2025, respectively. With an average price target of $16.67 between Citigroup, B of A Securities, and UBS, there's an implied 9.29% upside for RXO Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
1
Jan
2
Feb
1
1
Mar
3
2
Apr
5
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
1.9
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Citigroup
B of A Securities
UBS
Goldman Sachs
Stifel

1calculated from analyst ratings

Analyst Ratings for RXO

Buy NowGet Alert
05/21/2025Buy Now18.03%Citigroup
Ariel Rosa68%
$15 → $18MaintainsNeutralGet Alert
05/16/2025Buy Now18.03%B of A Securities
Ken Hoexter62%
$15 → $18MaintainsNeutralGet Alert
05/08/2025Buy Now-8.2%UBS
Thomas Wadewitz70%
$24 → $14MaintainsNeutralGet Alert
05/08/2025Buy Now18.03%Goldman Sachs
Jordan Alliger67%
$21 → $18MaintainsNeutralGet Alert
05/08/2025Buy Now-8.2%Stifel
J. Bruce Chan46%
$24 → $14MaintainsHoldGet Alert
05/08/2025Buy Now-1.64%Wells Fargo
Christian Wetherbee72%
$20 → $15MaintainsEqual-WeightGet Alert
04/24/2025Buy Now24.59%Truist Securities
Lucas Servera55%
$24 → $19MaintainsBuyGet Alert
04/11/2025Buy Now31.15%Jefferies
Stephanie Moore60%
$26 → $20MaintainsBuyGet Alert
04/10/2025Buy Now37.7%Goldman Sachs
Jordan Alliger67%
$24 → $21MaintainsNeutralGet Alert
04/08/2025Buy Now-1.64%Citigroup
Ariel Rosa68%
$23 → $15MaintainsNeutralGet Alert
04/04/2025Buy NowOppenheimer
Scott Schneeberger64%
DowngradeOutperform → PerformGet Alert
04/02/2025Buy Now44.26%Barclays
Brandon Oglenski61%
$24 → $22MaintainsOverweightGet Alert
03/27/2025Buy Now31.15%Wells Fargo
Christian Wetherbee72%
$22 → $20MaintainsEqual-WeightGet Alert
03/26/2025Buy Now-14.75%Susquehanna
Bascome Majors60%
$18 → $13MaintainsNegativeGet Alert
03/13/2025Buy Now57.38%Truist Securities
Lucas Servera55%
→ $24Initiates → BuyGet Alert
02/06/2025Buy Now57.38%Goldman Sachs
Jordan Alliger67%
$28 → $24MaintainsNeutralGet Alert
02/06/2025Buy Now57.38%Stifel
J. Bruce Chan46%
$27 → $24MaintainsHoldGet Alert
02/06/2025Buy Now63.93%Morgan Stanley
Ravi Shanker57%
$27 → $25MaintainsEqual-WeightGet Alert
01/23/2025Buy Now77.05%Stifel
J. Bruce Chan46%
$26 → $27MaintainsHoldGet Alert
01/17/2025Buy Now96.72%Barclays
Brandon Oglenski61%
$32 → $30MaintainsOverweightGet Alert
01/15/2025Buy NowBenchmark
Christopher Kuhn55%
ReiteratesHold → HoldGet Alert
01/10/2025Buy Now96.72%Jefferies
Stephanie Moore60%
$33 → $30MaintainsBuyGet Alert
01/07/2025Buy Now83.61%Wells Fargo
Christian Wetherbee72%
$31 → $28MaintainsEqual-WeightGet Alert
11/18/2024Buy Now90.16%Goldman Sachs
Jordan Alliger67%
→ $29Reinstates → NeutralGet Alert
11/12/2024Buy Now-21.31%Susquehanna
Bascome Majors60%
$16 → $12MaintainsNegativeGet Alert
11/12/2024Buy Now116.39%Citigroup
Ariel Rosa68%
$33 → $33DowngradeBuy → NeutralGet Alert
11/11/2024Buy Now103.28%Wells Fargo
Allison Poliniak70%
→ $31ReinstatesEqual-Weight → Equal-WeightGet Alert
10/15/2024Buy NowBenchmark
Christopher Kuhn70%
Reiterates → HoldGet Alert
10/09/2024Buy Now116.39%Citigroup
Ariel Rosa68%
→ $33Initiates → BuyGet Alert
09/26/2024Buy Now4.92%Susquehanna
Bascome Majors60%
$20 → $16MaintainsNegativeGet Alert
09/17/2024Buy Now103.28%Oppenheimer
Scott Schneeberger64%
$31 → $31ReiteratesOutperform → OutperformGet Alert
08/15/2024Buy Now31.15%Susquehanna
Bascome Majors60%
$14 → $20MaintainsNegativeGet Alert
08/13/2024Buy Now103.28%Jefferies
Stephanie Moore60%
$33 → $31MaintainsBuyGet Alert
08/13/2024Buy NowBenchmark
Christopher Kuhn70%
Reiterates → HoldGet Alert
08/12/2024Buy Now70.49%Morgan Stanley
Ravi Shanker57%
$19 → $26MaintainsEqual-WeightGet Alert
08/08/2024Buy Now83.61%TD Cowen
Jason Seidl53%
$23 → $28MaintainsHoldGet Alert
08/08/2024Buy Now70.49%JP Morgan
Brian Ossenbeck64%
$25 → $26MaintainsUnderweightGet Alert
08/08/2024Buy Now103.28%Oppenheimer
Scott Schneeberger64%
$22 → $31MaintainsOutperformGet Alert
08/08/2024Buy Now103.28%UBS
Joseph Parkhill75%
$22 → $31MaintainsNeutralGet Alert
07/16/2024Buy Now96.72%Barclays
Brandon Oglenski61%
$24 → $30MaintainsOverweightGet Alert
07/09/2024Buy Now63.93%JP Morgan
Brian Ossenbeck64%
$16 → $25MaintainsUnderweightGet Alert
06/12/2024Buy NowBenchmark
Christopher Kuhn70%
Reiterates → HoldGet Alert
05/15/2024Buy NowRaymond James
Felix Boeschen70%
Reinstates → Market PerformGet Alert
05/06/2024Buy Now44.26%Stephens & Co.
Daniel Imbro67%
$22 → $22ReiteratesEqual-Weight → Equal-WeightGet Alert
04/19/2024Buy NowBenchmark
Christopher Kuhn70%
Reiterates → HoldGet Alert
03/26/2024Buy Now4.92%Susquehanna
Bascome Majors60%
$15 → $16MaintainsNegativeGet Alert
03/25/2024Buy Now4.92%Susquehanna
Bascome Majors60%
$15 → $16MaintainsNegativeGet Alert
02/13/2024Buy Now44.26%Oppenheimer
Scott Schneeberger64%
$23 → $22MaintainsOutperformGet Alert
02/09/2024Buy Now-1.64%Susquehanna
Bascome Majors60%
$18 → $15MaintainsNegativeGet Alert
02/08/2024Buy Now44.26%B of A Securities
Ken Hoexter62%
$25 → $22DowngradeBuy → NeutralGet Alert
01/10/2024Buy Now44.26%Stifel
J. Bruce Chan46%
$20 → $22MaintainsHoldGet Alert
01/10/2024Buy Now50.82%Vertical Research
Jeffrey Kauffman63%
→ $23DowngradeBuy → HoldGet Alert
10/16/2023Buy Now11.48%Stifel
J. Bruce Chan46%
$19 → $17MaintainsHoldGet Alert
10/11/2023Buy Now4.92%JP Morgan
Brian Ossenbeck64%
$17 → $16DowngradeNeutral → UnderweightGet Alert
10/03/2023Buy Now-14.75%Susquehanna
Bascome Majors60%
$14 → $13MaintainsNegativeGet Alert
10/02/2023Buy Now18.03%Morgan Stanley
Ravi Shanker57%
$20 → $18MaintainsEqual-WeightGet Alert
08/31/2023Buy Now-8.2%Susquehanna
Bascome Majors60%
$19 → $14DowngradeNeutral → NegativeGet Alert
08/07/2023Buy Now57.38%Oppenheimer
Scott Schneeberger64%
→ $24ReiteratesOutperform → OutperformGet Alert
08/03/2023Buy Now31.15%Morgan Stanley
Ravi Shanker57%
$20 → $20ReiteratesEqual-Weight → Equal-WeightGet Alert
08/03/2023Buy Now24.59%Stephens & Co.
Jack Atkins63%
$23 → $19MaintainsEqual-WeightGet Alert
07/12/2023Buy Now24.59%Wolfe Research
Scott Group57%
→ $19DowngradePeer Perform → UnderperformGet Alert
07/06/2023Buy Now31.15%Morgan Stanley
Ravi Shanker57%
$20 → $20ReiteratesEqual-Weight → Equal-WeightGet Alert
06/09/2023Buy Now31.15%Susquehanna
Bascome Majors60%
→ $20Initiates → NeutralGet Alert
05/24/2023Buy Now77.05%Barclays
Brandon Oglenski61%
→ $27Initiates → OverweightGet Alert
05/04/2023Buy Now37.7%Wells Fargo
Allison Poliniak70%
$22 → $21MaintainsEqual-WeightGet Alert
04/04/2023Buy NowBenchmark
Christopher Kuhn70%
Initiates → HoldGet Alert
02/27/2023Buy Now44.26%Cowen & Co.
Jason Seidl53%
→ $22Initiates → Market PerformGet Alert
02/09/2023Buy Now50.82%UBS
Joseph Parkhill75%
$20 → $23MaintainsNeutralGet Alert
02/09/2023Buy Now44.26%Goldman Sachs
Jordan Alliger67%
$20 → $22MaintainsNeutralGet Alert
02/09/2023Buy Now57.38%Oppenheimer
Scott Schneeberger64%
$21 → $24MaintainsOutperformGet Alert
02/08/2023Buy Now31.15%Stephens & Co.
Jack Atkins63%
→ $20MaintainsEqual-WeightGet Alert
01/11/2023Buy Now11.48%Stifel
J. Bruce Chan46%
$20 → $17DowngradeBuy → HoldGet Alert
01/09/2023Buy Now24.59%JP Morgan
Brian Ossenbeck64%
→ $19Initiates → NeutralGet Alert
12/20/2022Buy Now18.03%Wells Fargo
Allison Poliniak70%
→ $18Initiates → Equal-WeightGet Alert
12/09/2022Buy Now31.15%UBS
Thomas Wadewitz70%
→ $20Initiates → NeutralGet Alert
12/09/2022Buy Now31.15%Morgan Stanley
Ravi Shanker57%
→ $20Initiates → Equal-WeightGet Alert
12/06/2022Buy Now63.93%Jefferies
Stephanie Moore60%
→ $25Initiates → BuyGet Alert
12/05/2022Buy NowRaymond James
Felix Boeschen70%
Initiates → Market PerformGet Alert
11/30/2022Buy Now44.26%B of A Securities
Ken Hoexter62%
→ $22Initiates → BuyGet Alert
11/22/2022Buy Now37.7%Oppenheimer
Scott Schneeberger64%
→ $21Initiates → OutperformGet Alert
11/22/2022Buy Now31.15%Goldman Sachs
Jordan Alliger67%
→ $20Initiates → NeutralGet Alert
11/21/2022Buy Now77.05%Vertical Research
Jeffrey Kauffman63%
→ $27Initiates → BuyGet Alert
11/10/2022Buy NowWolfe Research
Scott Group57%
Initiates → Peer PerformGet Alert
11/04/2022Buy Now31.15%Stifel
J. Bruce Chan46%
→ $20Initiates → BuyGet Alert

FAQ

Q

What is the target price for RXO (RXO) stock?

A

The latest price target for RXO (NYSE:RXO) was reported by Citigroup on May 21, 2025. The analyst firm set a price target for $18.00 expecting RXO to rise to within 12 months (a possible 18.03% upside). 42 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for RXO (RXO)?

A

The latest analyst rating for RXO (NYSE:RXO) was provided by Citigroup, and RXO maintained their neutral rating.

Q

When was the last upgrade for RXO (RXO)?

A

There is no last upgrade for RXO

Q

When was the last downgrade for RXO (RXO)?

A

The last downgrade for RXO Inc happened on April 4, 2025 when Oppenheimer changed their price target from N/A to N/A for RXO Inc.

Q

When is the next analyst rating going to be posted or updated for RXO (RXO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RXO, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RXO was filed on May 21, 2025 so you should expect the next rating to be made available sometime around May 21, 2026.

Q

Is the Analyst Rating RXO (RXO) correct?

A

While ratings are subjective and will change, the latest RXO (RXO) rating was a maintained with a price target of $15.00 to $18.00. The current price RXO (RXO) is trading at is $15.25, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch